Polypectomy in Patients Taking Dual Antiplatelet Agents

• Status: Unknown status
• Trial end date: 2019-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Current guidelines recommend discontinuation of antiplatelets (i.e clopidogrel) for 7 days in patients taking DAT (dual antiplatelet therapy) before colonoscopy and polypectomy. The purpose of this study was to examine if a) discontinuation of these drugs reduces bleeding risks during polypectomy and if b) discontinuation of these drugs increases the occurence of thromboembolic events.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Incheon St.Mary's Hospital
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• patients over the age of 20 years undergoing routine colonoscopy

• patients who are taking DAT (dual antiplatelet therapy)

Exclusion Criteria:

• patients not abiding to the study protocol

• history of inflammatory bowel disease

• severe comorbidities

• American Society of Anesthesiology class III or more

• pregnancy